相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Technical aspects and inter-laboratory variability in native peptide profiling: The CE-MS experience
Harald Mischak et al.
CLINICAL BIOCHEMISTRY (2013)
A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus
S. S. Roscioni et al.
DIABETOLOGIA (2013)
Chronic kidney disease: global dimension and perspectives
Vivekanand Jha et al.
LANCET (2013)
CKD273, a New Proteomics Classifier Assessing CKD and Its Prognosis
Angel Argiles et al.
PLOS ONE (2013)
Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy
Petra Zuerbig et al.
DIABETES (2012)
Implementation of proteomic biomarkers: making it work
Harald Mischak et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)
A comparison between MALDI-MS and CE-MS data for biomarker assessment in chronic kidney diseases
L. Molin et al.
JOURNAL OF PROTEOMICS (2012)
Mechanisms and Treatment of CKD
Piero Ruggenenti et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
How to get proteomics to the clinic? Issues in clinical proteomics, exemplified by CE-MS
Harald Mischak
PROTEOMICS CLINICAL APPLICATIONS (2012)
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants
Goodarz Danaei et al.
LANCET (2011)
Human urinary peptide database for multiple disease biomarker discovery
Justyna Siwy et al.
PROTEOMICS CLINICAL APPLICATIONS (2011)
Should Microalbuminuria Ever Be Considered as a Renal Endpoint in Any Clinical Trial?
Richard J. Glassock
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Should Microalbuminuria Ever Be Considered as a Renal Endpoint in Any Clinical Trial?
Hiddo J. Lambers Heerspink et al.
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Addressing the Challenge of Defining Valid Proteomic Biomarkers and Classifiers
Mohammed Dakna et al.
BMC BIOINFORMATICS (2010)
In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria
Bruce A. Perkins et al.
KIDNEY INTERNATIONAL (2010)
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
David M. Good et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
Harald Mischak et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Quantitative Urinary Proteome Analysis for Biomarker Evaluation in Chronic Kidney Disease
Justyna Jantos-Siwy et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Identification and Validation of Urinary Biomarkers for Differential Diagnosis and Evaluation of Therapeutic Intervention in Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
Marion Haubitz et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapy
Kasper Rossing et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Discovery and validation of urinary biomarkers for propstate cancer
Dan Theodorescu et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics
Joshua J. Coon et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Proteomic analysis of alpha-1-antitrypsin in immunoglobulin A nephropathy
Noh-Jin Kwak et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
Urine biomarkers predict the cause of glomerular disease
Sanju A. Varghese et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Repetitive fragmentation products of albumin and α1-antitrypsin in glomerular diseases associated with nephrotic syndrome
Giovanni Candiano et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2006)
Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry:: Towards new diagnostic and therapeutic approaches
S Wittke et al.
ELECTROPHORESIS (2005)
Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry
NV Neuhoff et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2004)
Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030
S Wild et al.
DIABETES CARE (2004)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
